Optimal Timing of Cardioverter-Defibrillator Implantation in Patients with Left Ventricular Dysfunction after Acute Myocardial Infarction

Optimal Timing of Cardioverter-Defibrillator Implantation in Patients with Left Ventricular Dysfunction after Acute Myocardial Infarction

Background: Prevention of sudden cardiac death (SCD) early after acute myocardial infarction (AMI) is still a challenge, without clear recommendations in spite of the high incidence of life-threatening ventricular arrhythmias, as implantable cardiac defibrillator (ICD) placement is not indicated in...

Full description

Bibliographic Details
Main Authors:	Andreea Maria Ursaru, Irina Iuliana Costache, Antoniu Octavian Petris, Mihai Stefan Cristian Haba, Ovidiu Mitu, Adrian Crisan, Nicolae Dan Tesloianu
Format:	Article
Language:	English
Published:	IMR Press 2022-04-01
Series:	Reviews in Cardiovascular Medicine
Subjects:	early icd implantation sudden cardiac death myocardial infarction arrhythmias primary prevention low ejection fraction heart failure icd therapies icd shock
Online Access:	https://www.imrpress.com/journal/RCM/23/4/10.31083/j.rcm2304124

Similar Items

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
by: Hans Römers, MSc, et al.
Published: (2023-01-01)

Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know
by: Andreea Maria Ursaru, et al.
Published: (2022-04-01)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
by: Omid Kiamanesh, MD, et al.
Published: (2015-07-01)

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Fibrous encapsulation of defibrillation electrode and elevated high-voltage impedance in patients with a subcutaneous implantable cardioverter-defibrillator
by: Jian-Ming Li, MD, PhD, FHRS, et al.
Published: (2020-03-01)

The subcutaneous implantable cardioverter defibrillator in daily clinical practice
by: Tardu Özkartal, et al.
Published: (2017-10-01)

Comparable Efficacy in Ischemic and Non-Ischemic ICD Recipients for the Primary Prevention of Sudden Cardiac Death
by: Andreea Maria Ursaru, et al.
Published: (2021-11-01)

Primary Prevention of Fatal Ventricular Arrhythmias With Implantable Cardioverter- Defibrillator Therapy – An Analysis of Implications Based on MADIT II Criteria
by: Zia I Carrim, et al.
Published: (2020-12-01)

Long-term survival of implantable cardioverter defibrillator recipients with end-stage renal disease
by: Mikhael F. El-Chami, MD, FACC, FHRS, et al.
Published: (2017-10-01)

Outcomes of single- or dual-chamber implantable cardioverter defibrillator systems in Japanese patients
by: Akiko Ueda, et al.
Published: (2016-04-01)

Unusual migration of implantable cardioverter defibrillator that clinically mimicking breast cancer: A case report
by: Abdulwahid M. Salih, et al.
Published: (2024-02-01)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
by: Luis A. Pires
Published: (2007-08-01)

Substernal implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with preexisting Hemodialysis Reliable Outflow graft
by: Thomas A. Boyle, et al.
Published: (2016-09-01)

Management of Implantable Cardioverter-Defibrillators during Pregnancy—A Systematic Review
by: Albert Topf, et al.
Published: (2021-04-01)

T-wave oversensing from postural changes: A rare cause of inappropriate shock from a subcutaneous defibrillator
by: Muhammad R. Afzal, MD, et al.
Published: (2017-08-01)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
by: Pier D. Lambiase, MBChB, PhD, FHRS, et al.
Published: (2020-12-01)

First Case Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator
by: Kosuke Takahari, MD, et al.
Published: (2023-09-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective
by: Martina Nesti, et al.
Published: (2023-10-01)

Paradox of Appropriate Implantable Cardioverter‐Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk
by: Ryan G. Aleong, et al.
Published: (2017-08-01)

Integrated approach for smart Implantable Cardioverter Defibrillator (ICD) device with real time ECG monitoring: Use of flexible sensors for localized arrhythmia sensing and stimulation
by: Munish ePuri, et al.
Published: (2013-10-01)

Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need
by: Yukiomi Tsuji, et al.
Published: (2021-02-01)

Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry
by: Vincenzo Russo, et al.
Published: (2022-05-01)

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
by: Valentino Ducceschi, et al.
Published: (2022-06-01)

Minimally invasive, pericardial implantable cardioverter-defibrillator placement in a young child
by: Wakana Maki, et al.
Published: (2017-10-01)

LAMP2 shines a light on cardiomyopathy in an athlete
by: Sophie Martin, MBBS, et al.
Published: (2017-03-01)

Subcutaneous implantable cardioverter-defibrillator (SICD) for sudden cardiac death - A case series
by: Viveka Kumar, et al.
Published: (2022-04-01)

Abdominal implantable cardioverter-defibrillator placement in a patient requiring bilateral chest radiation therapy
by: Ankur A. Karnik, MD, FHRS, CCDS, et al.
Published: (2016-09-01)

Arrhythmogenic right ventricular cardiomyopathy: A case report and review of literature
by: Shabarinath S, et al.
Published: (2016-03-01)

Postoperative intravenous patient‐controlled analgesia improves pain management after subcutaneous implantable defibrillator implantation
by: Kenta Tsutsui, et al.
Published: (2024-04-01)

Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
by: François D. Regoli, et al.
Published: (2023-01-01)

Single-chamber Versus Dual-chamber Implantable Cardioverter Defibrillators: Do We Need Physiologic Pacing in The Course?
by: Marco Budeus, et al.
Published: (2006-07-01)

Beyond MADIT
by: Peerawut Deeprasertkul, et al.
Published: (2013-12-01)

Recurrent episodes of ventricular tachycardia in a patient with Brugada syndrome was converted by implantable cardioverter defibrillator (ICD)
by: Milanov Zoran, et al.
Published: (2015-01-01)

Revision of subcutaneous implantable cardioverter defibrillator to intermuscular pocket to prevent inappropriate shocks
by: Jeko M. Madjarov, et al.
Published: (2020-06-01)

Turning a blind eye to the far field: Are we burying the evidence? A case of abrupt catastrophic implantable cardioverter defibrillator lead failure causing sudden death
by: Stephen Tuohy, MD, et al.
Published: (2016-01-01)

Diagnosis Coding for Clinicians: Core Knowledge and Transition to ICD-10
by: Davoren Chick, et al.
Published: (2014-06-01)

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
by: Yasuhisa Nakao, et al.
Published: (2020-03-01)

Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk Stratification
by: Luigi Pannone, et al.
Published: (2021-04-01)

Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
by: Sarah Wolf, et al.
Published: (2023-04-01)